Qingchun Li

554 total citations
18 papers, 455 citations indexed

About

Qingchun Li is a scholar working on Physiology, Nutrition and Dietetics and Endocrine and Autonomic Systems. According to data from OpenAlex, Qingchun Li has authored 18 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Nutrition and Dietetics and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Qingchun Li's work include Pain Mechanisms and Treatments (5 papers), Regulation of Appetite and Obesity (3 papers) and Adipose Tissue and Metabolism (3 papers). Qingchun Li is often cited by papers focused on Pain Mechanisms and Treatments (5 papers), Regulation of Appetite and Obesity (3 papers) and Adipose Tissue and Metabolism (3 papers). Qingchun Li collaborates with scholars based in China and Taiwan. Qingchun Li's co-authors include Zheng‐Yao Jiang, Haiyan Wang, Hangping Zheng, Xiaoxia Liu, Bin Lü, Shuo Zhang, Lijin Ji, Xiaoming Zhu, Qian Xiong and Shengli Wu and has published in prestigious journals such as PLoS ONE, Surgical Endoscopy and Diabetes Research and Clinical Practice.

In The Last Decade

Qingchun Li

18 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingchun Li China 12 175 143 122 76 61 18 455
Edyta Adamska-Patruno Poland 17 252 1.4× 106 0.7× 106 0.9× 120 1.6× 187 3.1× 48 649
Halil Erol Türkiye 12 212 1.2× 235 1.6× 146 1.2× 63 0.8× 37 0.6× 27 583
Panagiotis Giannogonas Greece 6 206 1.2× 65 0.5× 152 1.2× 42 0.6× 115 1.9× 6 548
Andrea G. Izquierdo Spain 14 313 1.8× 149 1.0× 161 1.3× 66 0.9× 193 3.2× 24 674
Amrita Khaire India 15 142 0.8× 64 0.4× 149 1.2× 104 1.4× 113 1.9× 23 641
Abhijit A. Ghadge India 9 143 0.8× 69 0.5× 179 1.5× 112 1.5× 93 1.5× 15 422
María Amil Spain 9 357 2.0× 150 1.0× 193 1.6× 94 1.2× 146 2.4× 10 655
Mar Grasa Spain 14 188 1.1× 105 0.7× 80 0.7× 221 2.9× 67 1.1× 34 529
Joshua J. Berger United States 6 160 0.9× 62 0.4× 74 0.6× 85 1.1× 93 1.5× 10 393
Saimai Chatree Thailand 11 79 0.5× 51 0.4× 65 0.5× 34 0.4× 69 1.1× 18 335

Countries citing papers authored by Qingchun Li

Since Specialization
Citations

This map shows the geographic impact of Qingchun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingchun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingchun Li more than expected).

Fields of papers citing papers by Qingchun Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingchun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingchun Li. The network helps show where Qingchun Li may publish in the future.

Co-authorship network of co-authors of Qingchun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qingchun Li. A scholar is included among the top collaborators of Qingchun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingchun Li. Qingchun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Zhang, Qi, Qingchun Li, Siying Liu, et al.. (2022). Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia. Diabetes Research and Clinical Practice. 186. 109806–109806. 28 indexed citations
3.
Zhang, Qi, Qingchun Li, Siying Liu, et al.. (2021). Decreased amino acids in the brain might contribute to the progression of diabetic neuropathic pain. Diabetes Research and Clinical Practice. 176. 108790–108790. 14 indexed citations
4.
Wang, Cheng‐Xiang, et al.. (2021). The Reproductive Toxicity of Monosodium Glutamate by Damaging GnRH Neurons Cannot Be Relieved Spontaneously Over Time. Drug Design Development and Therapy. Volume 15. 3499–3508. 5 indexed citations
5.
Zhang, He, et al.. (2021). Mechanism of Propofol-Lidocaine Hydrochloride Nano-Emulsion on Retinal Ganglion Cytopathic Effect in Diabetic Rats. Journal of Biomaterials and Tissue Engineering. 12(1). 36–44. 2 indexed citations
6.
Zheng, Hangping, Xiaona Qiao, Qi Zhang, et al.. (2019). The impact on glycemic control through progressive resistance training with bioDensityTM in Chinese elderly patients with type 2 diabetes. Diabetes Research and Clinical Practice. 150. 64–71. 26 indexed citations
7.
Zheng, Hangping, Lijin Ji, Xiaoxia Liu, et al.. (2019). The Preventive Effect of IL-1beta Antagonist on Diabetic Peripheral Neuropathy. Endocrine Metabolic & Immune Disorders - Drug Targets. 20(5). 753–759. 18 indexed citations
8.
Li, Qingchun, Tiansong Zhang, Ruiyun Zhang, et al.. (2019). Quantitative analysis of corneal nerve fibers in type 2 diabetics with and without diabetic peripheral neuropathy: Comparison of manual and automated assessments. Diabetes Research and Clinical Practice. 151(23). 33–38. 26 indexed citations
9.
Li, Qingchun, et al.. (2018). Arcuate nucleus neurons are not essential for the preprandial peak in plasma ghrelin after neonatal monosodium glutamate treatment. International Journal of Molecular Medicine. 41(3). 1635–1642. 3 indexed citations
10.
Zhang, Qi, Lijin Ji, Hangping Zheng, et al.. (2018). Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 146. 1–7. 29 indexed citations
11.
Ma, Zhenhua, et al.. (2017). Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production. PLoS ONE. 12(8). e0183426–e0183426. 49 indexed citations
12.
Xiong, Qian, Bin Lü, Hongying Ye, et al.. (2017). Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy. Diabetes Research and Clinical Practice. 136. 85–92. 16 indexed citations
13.
Zhang, Hua, et al.. (2017). The role of nesfatin-1 expression in letrozole-induced polycystic ovaries in the rat. Gynecological Endocrinology. 33(6). 438–441. 20 indexed citations
14.
Tian, Yuan, Qingchun Li, Yun Liang, & Guangrui Hu. (2016). Enhanced therapeutic efficacy and amelioration of cisplatin-induced nephrotoxicity by quercetin in 1,2-dimethyl hydrazine-induced colon cancer in rats. Indian Journal of Pharmacology. 48(2). 168–168. 30 indexed citations
15.
Sun, Ming, et al.. (2012). [Effect of tetrandrine on bax, bcl-2 and TGF-β2 mRNA expressions in cultured human Tenon's capsule fibroblasts].. PubMed. 32(1). 97–100. 1 indexed citations
16.
Zhou, Zhenhai, Shu-Ming Li, Yingjie Liu, et al.. (2010). [Study on the relationship between behavioral factors, psychological status and HIV infection among men who have sex with men in Beijing.].. PubMed. 31(3). 273–6. 14 indexed citations
17.
Li, Qingchun, et al.. (2010). Ghrelin acts on rat dorsal vagal complex to stimulate feeding via arcuate neuropeptide Y/agouti-related peptide neurons activation.. PubMed. 62(4). 357–64. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026